BG51159A3 - Process for the preparation of 1h, 3h-pyrrhol(1,2-c)thiazole-7-carboxamide derivatives - Google Patents
Process for the preparation of 1h, 3h-pyrrhol(1,2-c)thiazole-7-carboxamide derivatives Download PDFInfo
- Publication number
- BG51159A3 BG51159A3 BG091500A BG9150090A BG51159A3 BG 51159 A3 BG51159 A3 BG 51159A3 BG 091500 A BG091500 A BG 091500A BG 9150090 A BG9150090 A BG 9150090A BG 51159 A3 BG51159 A3 BG 51159A3
- Authority
- BG
- Bulgaria
- Prior art keywords
- radical
- alkyl
- phenyl
- pyridyl
- optionally substituted
- Prior art date
Links
- 229940053202 antiepileptics carboxamide derivative Drugs 0.000 title 1
- -1 quinoclidinyl Chemical group 0.000 abstract 11
- 125000000217 alkyl group Chemical group 0.000 abstract 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 8
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 4
- 125000004076 pyridyl group Chemical group 0.000 abstract 4
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical group C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 abstract 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 abstract 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical group C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000003282 alkyl amino group Chemical group 0.000 abstract 2
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 125000004193 piperazinyl group Chemical group 0.000 abstract 2
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
- 125000004485 2-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])C1([H])* 0.000 abstract 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 abstract 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 210000002249 digestive system Anatomy 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 125000005956 isoquinolyl group Chemical group 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- KHUXNRRPPZOJPT-UHFFFAOYSA-N phenoxy radical Chemical compound O=C1C=C[CH]C=C1 KHUXNRRPPZOJPT-UHFFFAOYSA-N 0.000 abstract 1
- 125000003884 phenylalkyl group Chemical group 0.000 abstract 1
- 125000005493 quinolyl group Chemical group 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical group C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BG9284390A BG51455A3 (en) | 1989-03-17 | 1990-03-06 | Process for the preparation derivatives of 1h-3h-pyrol/1,2-c/thiazole-7-carboxamide |
BG092844A BG50610A3 (en) | 1989-03-17 | 1990-03-16 | Method for the preparation of derivatives of 1h, 3h- pyrol (1, 2- c) thiazole- 7- carboxamide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8903510A FR2644456B1 (fr) | 1989-03-17 | 1989-03-17 | Nouveaux derives du 1h, 3h-pyrrolo(1,2-c)thiazolecarboxamide-7, leur preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
BG51159A3 true BG51159A3 (en) | 1993-02-15 |
Family
ID=9379793
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG091500A BG51159A3 (en) | 1989-03-17 | 1990-03-16 | Process for the preparation of 1h, 3h-pyrrhol(1,2-c)thiazole-7-carboxamide derivatives |
Country Status (24)
Country | Link |
---|---|
US (1) | US5086051A (es) |
EP (1) | EP0388309B1 (es) |
JP (1) | JPH02289586A (es) |
KR (1) | KR900014408A (es) |
AT (1) | ATE102210T1 (es) |
BG (1) | BG51159A3 (es) |
CA (1) | CA2012343A1 (es) |
CS (2) | CS438990A3 (es) |
DD (1) | DD297822A5 (es) |
DE (1) | DE69006872T2 (es) |
DK (1) | DK0388309T3 (es) |
ES (1) | ES2062432T3 (es) |
FI (1) | FI92069C (es) |
FR (1) | FR2644456B1 (es) |
IE (1) | IE63313B1 (es) |
IL (1) | IL93760A (es) |
MA (1) | MA21771A1 (es) |
MX (1) | MX26542A (es) |
NO (1) | NO172392C (es) |
NZ (1) | NZ232960A (es) |
PL (1) | PL284321A1 (es) |
PT (1) | PT93485B (es) |
TN (1) | TNSN90030A1 (es) |
ZA (1) | ZA902033B (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW214545B (es) * | 1992-02-17 | 1993-10-11 | Ciba Geigy Ag | |
US5639782A (en) * | 1992-03-04 | 1997-06-17 | Center For Innovative Technology | Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors |
US5530141A (en) * | 1992-03-04 | 1996-06-25 | Center For Innovative Technology | 2,4-diaryl-1,3-dithiolanes; 2,4-diaryl-1,3-dioxolanes; 2,4-diaryl-1,3-oxathiolanes; and 2,5-diaryl-1,3-oxathiolanes for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
US5358938A (en) * | 1992-07-13 | 1994-10-25 | Cytomed, Inc. | Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
US5463083A (en) * | 1992-07-13 | 1995-10-31 | Cytomed, Inc. | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
CA2140034A1 (en) | 1992-07-13 | 1994-01-20 | Xiong Cai | 2,5-diaryl tetrahydro-thiophenes, -furans and analogs for the treatment of inflammatory and immune disorders |
US5434151A (en) * | 1992-08-24 | 1995-07-18 | Cytomed, Inc. | Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
US5648486A (en) * | 1992-07-13 | 1997-07-15 | Cytomed, Inc. | Compounds and methods for the treatment of inflammatory and immune disorders |
TW266206B (es) * | 1993-04-28 | 1995-12-21 | Takeda Pharm Industry Co Ltd | |
US5703093A (en) * | 1995-05-31 | 1997-12-30 | Cytomed, Inc. | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
US5792776A (en) * | 1994-06-27 | 1998-08-11 | Cytomed, Inc., | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
US5750565A (en) * | 1995-05-25 | 1998-05-12 | Cytomed, Inc. | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
US5891895A (en) * | 1996-04-15 | 1999-04-06 | Takeda Chemical Industries, Ltd. | Hydroxypyridine derivatives their production and use |
JP5169216B2 (ja) * | 2005-08-19 | 2013-03-27 | 独立行政法人産業技術総合研究所 | 色可逆変化表示装置用電極体及びその製造方法、並びに色可逆変化表示装置及び色可逆変化調光装置 |
WO2009125434A2 (en) * | 2008-04-07 | 2009-10-15 | Cadila Healthcare Limited | Oxime derivatives |
WO2014192023A1 (en) * | 2013-05-22 | 2014-12-04 | Cadila Healthcare Limited | Novel compounds suitable for the treatment of dyslipidemia |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2541280B1 (fr) * | 1983-01-13 | 1985-06-21 | Rhone Poulenc Sante | Nouveaux derives du 1h, 3h-pyrrolo (1,2c) thiazolecarboxamide-7, leur preparation et les medicaments qui les contiennent |
FR2601016B1 (fr) * | 1986-07-04 | 1988-10-07 | Rhone Poulenc Sante | Nouveaux derives du 1h,3h-pyrrolo (1,2-c) thiazole, leur preparation et les compositions pharmaceutiques qui les contiennent |
FR2601015B1 (fr) * | 1986-07-04 | 1988-08-05 | Rhone Poulenc Sante | Nouveaux derives du 1h,3h-pyrrolo (1,2-c) thiazole, leur preparation et les compositions pharmaceutiques qui les contiennent |
-
1989
- 1989-03-17 FR FR8903510A patent/FR2644456B1/fr not_active Expired - Lifetime
-
1990
- 1990-03-12 MA MA22035A patent/MA21771A1/fr unknown
- 1990-03-14 US US07/493,439 patent/US5086051A/en not_active Expired - Fee Related
- 1990-03-15 CS CS904389A patent/CS438990A3/cs unknown
- 1990-03-15 PL PL28432190A patent/PL284321A1/xx unknown
- 1990-03-15 MX MX2654290A patent/MX26542A/es unknown
- 1990-03-15 DD DD90338778A patent/DD297822A5/de not_active IP Right Cessation
- 1990-03-15 CS CS901252A patent/CS276785B6/cs unknown
- 1990-03-15 IL IL9376090A patent/IL93760A/en not_active IP Right Cessation
- 1990-03-16 AT AT90400704T patent/ATE102210T1/de not_active IP Right Cessation
- 1990-03-16 IE IE98490A patent/IE63313B1/en not_active IP Right Cessation
- 1990-03-16 TN TNTNSN90030A patent/TNSN90030A1/fr unknown
- 1990-03-16 NZ NZ232960A patent/NZ232960A/xx unknown
- 1990-03-16 DK DK90400704.4T patent/DK0388309T3/da active
- 1990-03-16 ES ES90400704T patent/ES2062432T3/es not_active Expired - Lifetime
- 1990-03-16 CA CA002012343A patent/CA2012343A1/fr not_active Abandoned
- 1990-03-16 NO NO901237A patent/NO172392C/no unknown
- 1990-03-16 EP EP90400704A patent/EP0388309B1/fr not_active Expired - Lifetime
- 1990-03-16 DE DE69006872T patent/DE69006872T2/de not_active Expired - Fee Related
- 1990-03-16 ZA ZA902033A patent/ZA902033B/xx unknown
- 1990-03-16 KR KR1019900003553A patent/KR900014408A/ko not_active Application Discontinuation
- 1990-03-16 PT PT93485A patent/PT93485B/pt not_active IP Right Cessation
- 1990-03-16 FI FI901325A patent/FI92069C/fi not_active IP Right Cessation
- 1990-03-16 BG BG091500A patent/BG51159A3/xx unknown
- 1990-03-17 JP JP2068010A patent/JPH02289586A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG51159A3 (en) | Process for the preparation of 1h, 3h-pyrrhol(1,2-c)thiazole-7-carboxamide derivatives | |
DK575887D0 (da) | Pyridinderivater med anti-ulcer aktivitet | |
HUP9802323A2 (hu) | Pirimidinszármazékok, eljárás előállításukra és az ezeket tartalmazó gyógyászati készítmények | |
BG60030B2 (bg) | Метод за получаване на (d)-алфа-етил-2-оксо-1- пиролидинацетамид | |
FR2538388B1 (fr) | Nouveaux derives de naphtalene- ou azanaphtalenecarboxamide, leurs procedes de preparation et leur utilisation comme medicaments | |
ES479933A1 (es) | Un procedimiento para la preparacion de derivados de amino- piridina. | |
DE68900717D1 (de) | Chinolinonderivate, ihre herstellung und ihre verwendung als arzneimittel. | |
DK26289A (da) | Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia | |
FR2659329B1 (fr) | Nouveaux derives d'imidazo [1,2-c] quinazoline, leur procede de preparation et les compositions pharmaceutiques les renfermant. | |
NO913391L (no) | Fremgangsmaate for fremstilling av nye hetrazepinoide syreamider. | |
ES8607953A1 (es) | Un procedimiento para la preparacion de nuevos derivados de triazina | |
NO994764L (no) | Nye pyridinderivater og farmasöytiske preparater inneholdende disse | |
DE59010865D1 (de) | N-substituierte naphthalimide, ihre herstellung und verwendung | |
EP0169009A3 (en) | Novel dihydropyridine derivatives and their production, formulation and use as pharmaceuticals | |
EP0325984A3 (en) | 5-substituted 1-/4-(1-pyrrolidinyl)-2-butynyl/-2-pyrrolidones and related compounds, a process for their preparation and their use as medicaments | |
BG50610A3 (en) | Method for the preparation of derivatives of 1h, 3h- pyrol (1, 2- c) thiazole- 7- carboxamide | |
FR2683221B1 (fr) | Nouveaux derives de cinnolinones-4, leur preparation et leur application en therapeutique. | |
DK608586D0 (da) | Polysubstituerede pyridin-1-oxider og fysiologisk aktive salte deraf, deres fremstilling og anvendelse som laegemidler | |
GR3026762T3 (en) | Pyridine derivatives, pharmaceutical compositions comprising the same, the use of the same for the manufacture of medicaments having therapeutic or preventative value, and a process for preparing the same | |
ES8103747A1 (es) | Procedimiento para la preparacion de 5,6,7,8-tetrahidropira-zolo (3,4-b)(1,5)diazepin-1h,4h-5,7-dionas | |
MY101878A (en) | 1,3,4-thiadiazole |